Cassaday & Co Wealth Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Cassaday & Co Wealth Management's RVMD Position: Q3 2026 in Review
Cassaday & Co Wealth Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 5 shares — an estimated $937 sold.
Cassaday & Co Wealth Management first reported a position in RVMD in Q1 2026 and held it in 2 quarters. The position peaked at $937 in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Cassaday & Co Wealth Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
- Cassaday & Co Wealth Management sold 5 Revolution Medicines shares in Q3 2026, an estimated $937.
- Cassaday & Co Wealth Management first reported a position in Revolution Medicines in Q1 2026 and held it in 2 quarters.
- Cassaday & Co Wealth Management's Revolution Medicines position peaked at $937 in Q2 2026.
- 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.